WallStreetZenWallStreetZen

NYSE: ANVS
Annovis Bio Inc Stock

$8.75+0.44 (+5.29%)
Updated May 20, 2024
ANVS Price
$8.75
Fair Value Price
N/A
Market Cap
$97.75M
52 Week Low
$4.79
52 Week High
$22.49
P/E
-1.71x
P/B
-29.14x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$47.53M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-3.33
Operating Cash Flow
-$35M
Beta
1.08
Next Earnings
Jun 12, 2024
Ex-Dividend
N/A
Next Dividend
N/A

ANVS Overview

Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. Its lead compound is ANVS401, which is in Phase 2a clinical trials for the treatment of Alzheimer's disease (AD), Parkinson's disease, Alzheimer's disease in Down Syndrome, and other chronic neurodegenerative disorders. The company is also developing ANVS405 for protecting the brain after traumatic brain injury and/or stroke; and ANVS301, which is in Phase I clinical trials to increase cognitive capability in later stages of AD and dementia. Annovis Bio, Inc. was founded in 2008 and is based in Berwyn, Pennsylvania.

Zen Score

Industry Average (22)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how ANVS scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

ANVS is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
ANVS is unprofitable, so we are unable to assess its PEG ratio
PEG Value Valuation
ANVS's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
There are 30 more ANVS due diligence checks available for Premium users.

Be the first to know about important ANVS news, forecast changes, insider trades & much more!

ANVS News

Valuation

ANVS price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-1.71x
Industry
8.16x
Market
31.12x

ANVS price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
-29.14x
Industry
6.06x

ANVS's financial health

Profit margin

Revenue
$0.0
Net Income
-$1.1M
Profit Margin
0%
ANVS's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$7.8M
Liabilities
$11.2M
Debt to equity
-3.33
ANVS's short-term assets ($7.81M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ANVS's short-term assets ($7.81M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ANVS's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
ANVS's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$7.0M
Investing
$0.0
Financing
$4.4M
ANVS's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

ANVS vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
ANVS$97.75M+5.29%-1.71x-29.14x
RLMD$97.76M-2.99%-1.04x1.36x
BNTC$98.08M+10.33%-106.84x8.53x
LPTX$98.34M-2.28%-1.21x2.08x
ATHA$96.59M0.00%-0.83x0.90x

Annovis Bio Stock FAQ

What is Annovis Bio's quote symbol?

(NYSE: ANVS) Annovis Bio trades on the NYSE under the ticker symbol ANVS. Annovis Bio stock quotes can also be displayed as NYSE: ANVS.

If you're new to stock investing, here's how to buy Annovis Bio stock.

What is the 52 week high and low for Annovis Bio (NYSE: ANVS)?

(NYSE: ANVS) Annovis Bio's 52-week high was $22.49, and its 52-week low was $4.79. It is currently -61.09% from its 52-week high and 82.67% from its 52-week low.

How much is Annovis Bio stock worth today?

(NYSE: ANVS) Annovis Bio currently has 11,171,480 outstanding shares. With Annovis Bio stock trading at $8.75 per share, the total value of Annovis Bio stock (market capitalization) is $97.75M.

Annovis Bio stock was originally listed at a price of $9.59 in Jan 29, 2020. If you had invested in Annovis Bio stock at $9.59, your return over the last 4 years would have been -8.76%, for an annualized return of -2.27% (not including any dividends or dividend reinvestments).

How much is Annovis Bio's stock price per share?

(NYSE: ANVS) Annovis Bio stock price per share is $8.75 today (as of May 20, 2024).

What is Annovis Bio's Market Cap?

(NYSE: ANVS) Annovis Bio's market cap is $97.75M, as of May 21, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Annovis Bio's market cap is calculated by multiplying ANVS's current stock price of $8.75 by ANVS's total outstanding shares of 11,171,480.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.